Benzoyl peroxide and tetrinoin, no much of a disruption there.
Apart from being readily standardised and available substances (unlike cannabidiol) with a known safety profile, the data is actually not that great with differences in lesion count between active and placebo in the single digits across all arms:In trial SGT-65-04, the absolute change from baseline of inflammatory lesion count for Twyneo was -21.6 versus -14.8 for the vehicle group (P<0.001). In trial SGT-65-05, the absolute change from baseline of inflammatory lesion count for Twyneo was -16.2 versus -14.1 for the vehicle group (P=0.021).
In trial SGT-65-04, the absolute change from baseline of non-inflammatory lesion count for Twyneo was -29.7 versus -19.8 for the vehicle group (P<0.001). In trial SGT-65-05, the absolute change from baseline of non-inflammatory lesion count for Twyneo was -24.2 versus -17.4 for the vehicle group (P<0.001).
- Forums
- ASX - By Stock
- "Case Study" - So Gel
Benzoyl peroxide and tetrinoin, no much of a disruption...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $606.3M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 32.5¢ | $1.001M | 3.017M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 1003521 | 32.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 127968 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 1003521 | 0.325 |
24 | 1582643 | 0.320 |
13 | 975958 | 0.315 |
17 | 1198817 | 0.310 |
18 | 469087 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 128000 | 6 |
0.335 | 680050 | 9 |
0.340 | 1028071 | 13 |
0.345 | 320442 | 7 |
0.350 | 282050 | 9 |
Last trade - 13.41pm 08/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |